Capital City Trust Co. FL Has $4.86 Million Stake in Colgate-Palmolive Company $CL

Capital City Trust Co. FL trimmed its position in Colgate-Palmolive Company (NYSE:CL) by 2.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,456 shares of the company’s stock after selling 1,466 shares during the quarter. Colgate-Palmolive accounts for 1.3% of Capital City Trust Co. FL’s portfolio, making the stock its 24th largest position. Capital City Trust Co. FL’s holdings in Colgate-Palmolive were worth $4,859,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Price T Rowe Associates Inc. MD raised its stake in Colgate-Palmolive by 18.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after acquiring an additional 5,269,140 shares in the last quarter. Nuveen LLC acquired a new position in Colgate-Palmolive during the first quarter worth $217,593,000. Goldman Sachs Group Inc. raised its stake in Colgate-Palmolive by 34.5% during the first quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock worth $747,762,000 after acquiring an additional 2,045,191 shares in the last quarter. Diamond Hill Capital Management Inc. raised its stake in Colgate-Palmolive by 45.0% during the first quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock worth $521,250,000 after acquiring an additional 1,727,105 shares in the last quarter. Finally, Alliancebernstein L.P. raised its stake in Colgate-Palmolive by 60.5% during the first quarter. Alliancebernstein L.P. now owns 2,336,783 shares of the company’s stock worth $218,957,000 after acquiring an additional 880,527 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $78.01 on Friday. The business’s 50-day simple moving average is $83.29 and its 200 day simple moving average is $88.32. The stock has a market cap of $63.05 billion, a price-to-earnings ratio of 21.91, a P/E/G ratio of 4.06 and a beta of 0.34. Colgate-Palmolive Company has a 12-month low of $77.91 and a 12-month high of $102.61. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 earnings per share. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is presently 58.43%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday, September 25th. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Morgan Stanley decreased their target price on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Colgate-Palmolive in a report on Saturday, September 27th. Seven analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus price target of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.